Australian researchers have demonstrated that the use of a new, less toxic drug combination after stem cell transplants for ...

Driven, athletic, and a role model to his community, 20-year-old Eddie Kaufman has been fighting an aggressive form of blood ...

Gene therapy is revolutionizing how they're treated, and the Fred Hutch Cancer Center in Seattle is at the center of it all. ...

DelveInsight’s, “Chronic Lymphocytic Leukemia Pipeline Insight 2025” report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Chronic Lymphocytic Leukemia (CLL) pipeline ...

A new cancer treatment discovered by the University of California, San Diego Sanford Stem Cell Institute (SSCI) and developed ...

Debiopharm ( a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standards of care to ...

High body mass index affects outcomes in acute lymphoblastic leukemia (ALL), highlighting the need for targeted interventions ...

PTCy plus cyclosporine proved more effective than standard GVHD prophylaxis in patients undergoing matched sibling PBSCT in a phase 3 trial.

HSPCs polarize in contact with bone marrow stromal cells constituting their niche. This study analyses the polarity of ...

During the early days of research on bone marrow transplants, the procedure was difficult for patients to endure and had a ...

Acute myeloid leukemia (AML) is an aggressive blood cancer characterized by the accumulation of immature myeloid cells. Current treatments often fail to achieve durable remission, underscoring the ...

A local car dealership has sent warm wishes to Franciscan cancer patients.